100 related articles for article (PubMed ID: 19042019)
1. Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia.
Tavernier-Tardy E; Cornillon J; Campos L; Flandrin P; Duval A; Nadal N; Guyotat D
Leuk Res; 2009 Jun; 33(6):764-8. PubMed ID: 19042019
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype.
Konoplev S; Rassidakis GZ; Estey E; Kantarjian H; Liakou CI; Huang X; Xiao L; Andreeff M; Konopleva M; Medeiros LJ
Cancer; 2007 Mar; 109(6):1152-6. PubMed ID: 17315232
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic significance of leukemia-associated phenotype in correlation with other biologic markers in acute myeloid leukemia patients].
Dăscălescu A; Zlei M; Grigore G; Dănăila C; Jitaru D; Carasevici E
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1176-81. PubMed ID: 20191895
[TBL] [Abstract][Full Text] [Related]
4. VLA-4 and CXCR4 expression levels show contrasting prognostic impact (favorable and unfavorable, respectively) in acute myeloid leukemia.
Bae MH; Oh SH; Park CJ; Lee BR; Kim YJ; Cho YU; Jang S; Lee JH; Kim N; Park SH; Lim JH; Seo EJ; Lee KH
Ann Hematol; 2015 Oct; 94(10):1631-8. PubMed ID: 26155911
[TBL] [Abstract][Full Text] [Related]
5. CXCR4 Overexpression is a Poor Prognostic Factor in Pediatric Acute Myeloid Leukemia With Low Risk: A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group.
Matsuo H; Nakamura N; Tomizawa D; Saito AM; Kiyokawa N; Horibe K; Nishinaka-Arai Y; Tokumasu M; Itoh H; Kamikubo Y; Nakayama H; Kinoshita A; Taga T; Tawa A; Taki T; Tanaka S; Adachi S
Pediatr Blood Cancer; 2016 Aug; 63(8):1394-9. PubMed ID: 27135782
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML.
Terwijn M; Feller N; van Rhenen A; Kelder A; Westra G; Zweegman S; Ossenkoppele G; Schuurhuis GJ
Eur J Cancer; 2009 Jun; 45(9):1692-9. PubMed ID: 19321337
[TBL] [Abstract][Full Text] [Related]
7. High CXCR4 and low VLA-4 expression predicts poor survival in adults with acute lymphoblastic leukemia.
Ko SY; Park CJ; Park SH; Cho YU; Jang S; Seo EJ; Kim N; Kim DY; Koh KN; Im HJ; Seo JJ; Chi HS
Leuk Res; 2014 Jan; 38(1):65-70. PubMed ID: 24239175
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia.
Mannelli F; Cutini I; Gianfaldoni G; Bencini S; Scappini B; Pancani F; Ponziani V; Bonetti MI; Biagiotti C; Longo G; Bosi A
Cytometry B Clin Cytom; 2014 Sep; 86(5):340-9. PubMed ID: 24500843
[TBL] [Abstract][Full Text] [Related]
9. Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: a study from the Acute Leukemia French Association.
Renneville A; Boissel N; Zurawski V; Llopis L; Biggio V; Nibourel O; Philippe N; Thomas X; Dombret H; Preudhomme C
Cancer; 2009 Aug; 115(16):3719-27. PubMed ID: 19536888
[TBL] [Abstract][Full Text] [Related]
10. Relationship between CXC chemokine receptor 4 expression and prognostic significance in acute myeloid leukemia.
Cao T; Ye Y; Liao H; Shuai X; Jin Y; Su J; Zheng Q
Medicine (Baltimore); 2019 Jun; 98(23):e15948. PubMed ID: 31169718
[TBL] [Abstract][Full Text] [Related]
11. Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
Koh Y; Park J; Ahn KS; Kim I; Bang SM; Lee JH; Yoon SS; Soon Lee D; Yiul Lee Y; Park S; Kim BK
Ann Hematol; 2009 Nov; 88(11):1089-97. PubMed ID: 19296110
[TBL] [Abstract][Full Text] [Related]
12. Platelet production and related pathophysiology in acute myelogenous leukemia at first diagnosis: prognostic implications.
Trafalis DT; Poulakidas E; Kapsimali V; Tsigris C; Papanicolaou X; Harhalakis N; Nikiforakis E; Mentzikof-Mitsouli C
Oncol Rep; 2008 Apr; 19(4):1021-6. PubMed ID: 18357391
[TBL] [Abstract][Full Text] [Related]
13. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
[TBL] [Abstract][Full Text] [Related]
14. Biphenotypic characteristics, cell size and prognosis in childhood acute myeloblastic leukemia.
Olcay L; Hiçsönmez G; Ertem U; Okur H; Tuncer AM
Turk J Pediatr; 1999; 41(2):219-24. PubMed ID: 10770661
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
Krauter J; Wagner K; Schäfer I; Marschalek R; Meyer C; Heil G; Schaich M; Ehninger G; Niederwieser D; Krahl R; Büchner T; Sauerland C; Schlegelberger B; Döhner K; Döhner H; Schlenk RF; Ganser A
J Clin Oncol; 2009 Jun; 27(18):3000-6. PubMed ID: 19380453
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
Lee JI; Jin BH; Kim MA; Yoon HJ; Hong SP; Hong SD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):678-84. PubMed ID: 19272813
[TBL] [Abstract][Full Text] [Related]
17. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
[TBL] [Abstract][Full Text] [Related]
18. Association of SDF-1 Gene Polymorphism with Increased Risk of Acute Myeloid Leukemia Patients.
Aladle DAAM; Ghannam MA; El-Ashwah S; Ghobrial FEI; Mortada MI
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1035-1043. PubMed ID: 33906294
[TBL] [Abstract][Full Text] [Related]
19. Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.
Büchner T; Berdel WE; Haferlach C; Haferlach T; Schnittger S; Müller-Tidow C; Braess J; Spiekermann K; Kienast J; Staib P; Grüneisen A; Kern W; Reichle A; Maschmeyer G; Aul C; Lengfelder E; Sauerland MC; Heinecke A; Wörmann B; Hiddemann W
J Clin Oncol; 2009 Jan; 27(1):61-9. PubMed ID: 19047294
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
